Chicago Blackhawks captain Jonathan Toews is still dealing with long COVID symptoms and Chronic Immune Response Syndrome, he said in a statement Sunday. Toews last played on Jan. 28 against Edmonton before taking a break to focus on his health.
Toews returned for the 2021-22 season and appeared in 71 games while adjusting to playing with his new health circumstances. He’s played his entire 15-year career in Chicago.Even after returning in 2021-22 and looking more like his old self this season, Toews frequently said he wasn’t quite back to 100 percent, and that he was working to find the energy and strength that once made him one of the best players in the world.Obviously, Toews won’t be traded ahead of the March 3 deadline now.
Besides, Toews has been great with the Blackhawks’ young players over the years and could serve as a bridge to the next generation — all while still selling tickets and jerseys. And he wouldn’t cost much at this point.Davidson said he expects a decision from Kane “soon” and he has been in communication with Kane and his agent. Davidson said he’ll work with Kane, who could waive his no-trade clause at the trade deadline, and do whatever Kane wants.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Britain's Got Talent performer on life after near-death fallParalysed Britain's Got Talent escapologist Jonathan Goodwin on his positive mindset and love.
Read more »
Exclusive: Ant-Man's Paul Rudd explains why Quantumania felt differentAnt-Man's Paul Rudd explains why Quantumania felt different
Read more »
The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation - Journal of NeuroinflammationPatients with COVID-19 can have a variety of neurological symptoms, but the active involvement of central nervous system (CNS) in COVID-19 remains unclear. While routine cerebrospinal fluid (CSF) analyses in patients with neurological manifestations of COVID-19 generally show no or only mild inflammation, more detailed data on inflammatory mediators in the CSF of patients with COVID-19 are scarce. We studied the inflammatory response in paired CSF and serum samples of patients with COVID-19 (n = 38). Patients with herpes simplex virus encephalitis (HSVE, n = 10) and patients with non-inflammatory, non-neurodegenerative neurological diseases (n = 28) served as controls. We used proteomics, enzyme-linked immunoassays, and semiquantitative cytokine arrays to characterize inflammatory proteins. Autoantibody screening was performed with cell-based assays and native tissue staining. RNA sequencing of long-non-coding RNA and circular RNA was done to study the transcriptome. Proteomics on single protein level and subsequent pathway analysis showed similar yet strongly attenuated inflammatory changes in the CSF of COVID-19 patients compared to HSVE patients with, e.g., downregulation of the apolipoproteins and extracellular matrix proteins. Protein upregulation of the complement system, the serpin proteins pathways, and other proteins including glycoproteins alpha-2 and alpha-1 acid. Importantly, calculation of interleukin-6, interleukin-16, and CXCL10 CSF/serum indices suggest that these inflammatory mediators reach the CSF from the systemic circulation, rather than being produced within the CNS. Antibody screening revealed no pathological levels of known neuronal autoantibodies. When stratifying COVID-19 patients into those with and without bacterial superinfection as indicated by elevated procalcitonin levels, inflammatory markers were significantly (p | 0.01) higher in those with bacterial superinfection. RNA sequencing in the CSF revealed 101 linear RNAs comprising mess
Read more »
The Masked Singer winner Rhino unmasked as Charlie Simpson in epic finaleJudges Rita Ora, Jonathan Ross, Davina McCall, and Mo Gilligan put in last-minute guesses for Jason Orange, George Ezra and James Arthur.
Read more »
Warning to anyone who's had Covid - it 'increases silent killer risk by 55%'COVID increases the risk of heart attacks and stroke by 55 per cent, a new study claims. US researchers found people infected with the virus had a greater chance of developing deadly heart disease.…
Read more »
How COVID-19 Changes the Heart—Even After the Virus Is GoneA study adds new evidence that SARS-CoV-2—the virus that causes COVID-19—could have a lasting impact on the heart.
Read more »